Future Treatment for COPD: Targeting Oxidative Stress and its Related Signal

Publisher: Bentham Science Publishers

E-ISSN: 2212-2710|7|1|1-11

ISSN: 1872-213X

Source: Recent Patents on Inflammation & Allergy Drug Discovery, Vol.7, Iss.1, 2013-01, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

COPD is pathogenically associated with oxidative stress, which originates not only from cigarette smoke, but also from hypoxia, infection, inflammation, and ageing. It is the reason that therapeutic strategies aim at attenuation of oxidative stress, its sources, or intracellular signals and pro-inflammatory network of its downstream. This review discusses the pathogenesis of COPD and its current therapy in viewpoint of oxidative stress and further provides the perspectives for new treatment strategies in COPD and recent patents that could develop into novel therapeutics.

Related content